256 related articles for article (PubMed ID: 14636064)
1. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
Shibata T; Yamada T; Kondo M; Tanahashi N; Tanaka K; Nakamura H; Masutani H; Yodoi J; Uchida K
Biochemistry; 2003 Dec; 42(47):13960-8. PubMed ID: 14636064
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis.
Kondo M; Shibata T; Kumagai T; Osawa T; Shibata N; Kobayashi M; Sasaki S; Iwata M; Noguchi N; Uchida K
Proc Natl Acad Sci U S A; 2002 May; 99(11):7367-72. PubMed ID: 12032289
[TBL] [Abstract][Full Text] [Related]
3. 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses.
Uchida K; Shibata T
Chem Res Toxicol; 2008 Jan; 21(1):138-44. PubMed ID: 18052108
[TBL] [Abstract][Full Text] [Related]
4. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.
Ishii T; Uchida K
Chem Res Toxicol; 2004 Oct; 17(10):1313-22. PubMed ID: 15487891
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
6. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
Lee DR; Kwon CH; Park JY; Kim YK; Woo JS
Toxicology; 2009 Apr; 258(1):17-24. PubMed ID: 19167456
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
10. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
[TBL] [Abstract][Full Text] [Related]
11. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
Emi M; Maeyama K
Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ
Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.
Kansanen E; Kivelä AM; Levonen AL
Free Radic Biol Med; 2009 Nov; 47(9):1310-7. PubMed ID: 19573595
[TBL] [Abstract][Full Text] [Related]
14. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
Kim EH; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
[TBL] [Abstract][Full Text] [Related]
15. 15-Deoxy-Delta(12,14)-prostaglandin J(2) impairs the functions of histone acetyltransferases through their insolubilization in cells.
Hironaka A; Morisugi T; Kawakami T; Miyagi I; Tanaka Y
Biochem Biophys Res Commun; 2009 Dec; 390(2):290-4. PubMed ID: 19799872
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
Katura T; Moriya T; Nakahata N
Mol Pharmacol; 2010 Apr; 77(4):601-11. PubMed ID: 20086036
[TBL] [Abstract][Full Text] [Related]
18. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).
Campo PA; Das S; Hsiang CH; Bui T; Samuel CE; Straus DS
Cell Growth Differ; 2002 Sep; 13(9):409-20. PubMed ID: 12354750
[TBL] [Abstract][Full Text] [Related]
19. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.
Kamagata C; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2007 May; 102(3):263-73. PubMed ID: 17028981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
